Case Studies

Page 1 of 5.

Trusted MR-guided radiotherapy planning

Europe’s health services face demands for breakthrough cancer therapies assured as safe, personalised, and able to cost-effectively treat patients. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagnosis. Image-guided radiation therapies becam...

read more

Absolute dosimetry for MR-Linacs

Should cancer incidence rates rise as predicted, Europe’s health services will face escalating demands for investment in advanced therapies assured as safe, personalised, and cost-effective. In 2020, 2.7 million people in the European Union received a cancer diagnosis. About half underwent radiotherapy, including during diagno...

read more

Combating infections with advanced DNA sequencing

Resistance to antibiotic treatments are responsible for approximately 33,000 deaths a year in Europe and infectious diseases were the leading cause of death among children under five. This includes bacteria that have developed resistance to Carbapenems, considered drugs of ‘last resort’ for Antimicrobial Resistance (AMR) infect...

read more

Innovation in molecular radiotherapy

In 2020, 2.7 million people in the European Union were diagnosed with cancer and 1.3 million lives were lost to the disease. The EU Commission supports research to improve prevention, detection, diagnosis and treatment of cancer. Quality of life for patients during treatment is also a priority, and is an important factor for ev...

read more

Calibration best practice in Standards

Infusion pumps, also known as syringe pumps, are used to automatically deliver critical fluids to patients at precisely programmed rates or intervals. When these devices are used to administer high-risk medications, inaccuracies in delivered flow rates can have significant safety implications; especially for drugs with narrow ...

read more

Enabling a quantitative approach to cardiovascular disease diagnostics

Over a third of all deaths in the EU are caused by disorders of the heart or blood vessels collectively described as cardiovascular disease (CVD), making it the leading cause of mortality. As well as the significant social toll, CVD is also estimated to cost the EU economy around €210 billion a year. The current ‘gold standard’...

read more
Page 1 of 5.
Element 1 Element 2 Element 3 Element 1 Element 1 Element 1 Element 1 Element 1 Logo-Footer